Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $5 | $22 |
| % Growth | -4.8% | -20% | -75.3% | – |
| Cost of Goods Sold | $1 | $2 | $2 | $7 |
| Gross Profit | $3 | $2 | $4 | $15 |
| % Margin | 69.3% | 44.4% | 68% | 66.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $1 |
| SG&A Expenses | $3 | $3 | $3 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $5 |
| Other Operating Expenses | $0 | $0 | $0 | $3 |
| Operating Expenses | $3 | $3 | $3 | $8 |
| Operating Income | -$1 | -$2 | -$1 | -$1 |
| % Margin | -27.1% | -43.4% | -22.9% | -5.5% |
| Other Income/Exp. Net | -$6 | -$5 | -$1 | -$7 |
| Pre-Tax Income | -$7 | -$7 | -$3 | -$8 |
| Tax Expense | $0 | -$3 | $0 | -$0 |
| Net Income | -$7 | -$3 | -$3 | -$8 |
| % Margin | -177.3% | -77% | -49.5% | -36.2% |
| EPS | -4.87 | -19.69 | -0.094 | -679.35 |
| % Growth | 75.3% | -20,891.5% | 100% | – |
| EPS Diluted | -4.87 | -19.69 | -0.23 | -0.68 |
| Weighted Avg Shares Out | 1 | 1 | 12 | 12 |
| Weighted Avg Shares Out Dil | 1 | 1 | 12 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$0 | -$2 | $1 | -$7 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$1 | -$15 |
| % Margin | -27.1% | -43.4% | -22.9% | -66.8% |